Synthesis, Characterization, and Biological Evaluation of Compartmental Thiosemicarbazone Metal Complexes

References

[1] Ackerman, L. J., West, D. X., Mathias, C. J., & Green, M. A. (1999). Synthesis and evaluation of copper radiopharmaceuticals with mixed bis (thiosemicarbazone) ligands. Nuclear medicine and biology, 26(5), 551-554.

[2] Aly, A. A., Ahmed, E. K., & Mohamed, G. G. (2014). Synthesis, characterization, and biological applications of 4 - methoxybenzaldehyde semicarbazone and thiosemicarbazone and their Mn (II) and Fe (III) complexes. International Journal of Advanced Research, 2(4), 397-407.

[3] Andres, S. A., Bajaj, K., Vishnosky, N. S., Peterson, M. A., Mashuta, M. S., Buchanan, R. M., ... & Grapperhaus, C. A. (2020). Synthesis, characterization, and biological activity of hybrid thiosemicarbazone–alkylthiocarbamate metal complexes. Inorganic Chemistry, 59(7), 4924- 4935.

[4] Arslan, B. A., Kaya, B., Şahin, O., Baday, S., Saylan, C. C., & Ülküseven, B. (2021). The iron (III) and nickel (II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2. Journal of Molecular Structure, 1246, 131166.

[5] Bai, X.-G., Zheng, Y., & Qi, J. (2022). Advances in thiosemicarbazone metal complexes as anti- lung cancer agents. Frontiers in Pharmacology, 13, 1018951.

[6] Dhariyal, K., Parveen, S., Kumar, S., Banerjee, M., Sharma, P., Singh, S. K., & Singh, A. K. (2022). Half-sandwich ruthenium–arene thiosemicarbazones complexes: Synthesis, characterization, biological evaluation and DFT calculations. Inorganic Chemistry Communications, 152, 110678

[7] Fathima, S. S. A., Meeran, M. M. S., & Nagarajan, E. R. (2020). Synthesis, characterization and biological evaluation of novel 2, 2′-((1, 2-diphenylethane-1, 2-diylidene) bis (azanylylidene)) bis (pyridin-3-ol) and metal complexes: molecular docking and in silico ADMET profile. Structural Chemistry, 31(2), 521-539.

[8] Gaber, A., Refat, M. S., Belal, A. A. M., El- Deen, I. M., Hassan, N., Zakaria, R., Alhomrani, M., Alamri, A. S., Alsanie, W. F., & Saied, E. M. (2021). New mononuclear and binuclear Cu (II), Co (II), Ni (II), and Zn (II) thiosemicarbazone complexes with potential biological activity: Antimicrobial and molecular docking study. Molecules, 26(8), 2288.

[9] Grieve, M. L., Davey, P. R., Forsyth, C. M., & Paterson, B. M. (2021). The synthesis of a bis (Thiosemicarbazone) macrocyclic ligand and the Mn (II), Co (II), Zn (II) and 68Ga (III) complexes. Molecules, 26(12), 3646.

[10] Gou, Y., Wang, J., Chen, S., Zhang, Z., Zhang, Y., Zhang, W., & Yang, F. (2016). α− N− heterocyclic thiosemicarbazone Fe (III) complex: Characterization of its antitumor activity and identification of anticancer mechanism. European Journal of Medicinal Chemistry, 123, 354-364.

[11] Gupta, S., Joshi, S., Hashmi, K., & Satya. (2022). Computational insights into thiosemicarbazone metal complexes: Structural elucidation, reactivity patterns, and biomedical implications. Proceedings, 105(1), 156.

[12] Kaya, B., Gholam Azad, M., Suleymanoglu, M., Harmer, J. R., Wijesinghe, T. P., Richardson, V., ... & Richardson, D. R. (2024). Isosteric Replacement of Sulfur to Selenium in a Thiosemicarbazone: Promotion of Zn (II) Complex Dissociation and Transmetalation to Augment Anticancer Efficacy. Journal of Medicinal Chemistry, 67(14), 12155-12183.

[13] Kizilcikli, İ., Kurt, Y. D., Akkurt, B., Genel, A. Y., Birteksoz, S., Otuk, G., & Ulkuseven, B. (2007). Antimicrobial activity of a series of thiosemicarbazones and their Zn (II) and Pd (II) complexes. Folia Microbiologica, 52(1), 15-25.

[14] Ladani, G. G., & Patel, M. P. (2015). Novel 1, 3, 4-oxadiazole motifs bearing a quinoline nucleus: synthesis, characterization and biological evaluation of their antimicrobial, antitubercular, antimalarial and cytotoxic activities. New Journal of Chemistry, 39(12), 9848-9857.

[15] Lapasam, A., Banothu, V., Addepally, U., & Kollipara, M. R. (2020). Half-sandwich arene ruthenium, rhodium and iridium thiosemicarbazone complexes: synthesis, characterization and biological evaluation. Journal of Chemical Sciences, 132, 1-10.

[16] Leovac, V. M., Bogdanović, G. A., Jovanović, L. S., Joksovic, L., Marković, V., Joksovic, M. D., & Dalovic, I. (2011). Synthesis, characterization and antitumor activity of polymeric copper (II) complexes with thiosemicarbazones of 3-methyl- 5-oxo-1-phenyl-3-pyrazolin-4-carboxaldehyde and 5 -oxo-3-phenyl-3-pyrazolin-4- carboxaldehyde. Journal of Inorganic Biochemistry, 105(11), 1413-1421.

[17] Maruthesh, H., Katagi, M., & Nandeshwarappa, B. (2022). A convenient synthesis, characterization and biological evaluation of novel schiff base heterocycles as potential antimicrobial, antitubercular agents and their structural activity relationship. Current Chemistry Letters, 12(4), 759-768.

[18] Muleta, F., Alansi, T., & Eswaramoorthy, R. (2019). A review on synthesis, characterization methods and biological activities of semicarbazone, thiosemicarbazone and their transition metal complexes. Journal of Natural Sciences Research, 9(17), 33-47

[19] Mahalingam, V., Chitrapriya, N., Fronczek, F. R., & Natarajan, K. (2008). Dimethyl sulfoxide ruthenium (II) complexes of thiosemicarbazones and semicarbazone: Synthesis, characterization and biological studies. Polyhedron, 27(13), 2743-2750.

[20] Pelosi, G. (2010). Thiosemicarbazone metal complexes: From structure to activity. The Open Crystallography Journal, 3(1), 16-28.

[21] Pervez, H., Chohan, Z. H., Ramzan, M., Nasim, F. U. H., & Khan, K. M. (2009). Synthesis and biological evaluation of some new N4- substituted isatin-3-thiosemicarbazones. Journal of enzyme inhibition and medicinal chemistry, 24(2), 437-446.

[22] Rani, M., Devi, J., & Kumar, B. (2022). Thiosemicarbazones-based Co (II), Ni (II), Cu (II), and Zn (II) complexes: Synthesis, structural elucidation, biological activities, and molecular docking. Chemical Papers, 77, 6007–6027.

[23] Stacy, A. E., Palanimuthu, D., Bernhardt, P. V., Kalinowski, D. S., Jansson, P. J., & Richardson, D. R. (2016). Zinc (II)–thiosemicarbazone complexes are localized to the lysosomal compartment where they transmetallate with copper ions to induce cytotoxicity. Journal of medicinal chemistry, 59(10), 4965-4984.

[24] Steele, B. R., & Kourkoumelis, N. (2020). Thiosemicarbazone complexes of transition metals as catalysts for cross-coupling reactions. Catalysts, 10(10), 1107.

@article{1703636,
      author = {Dr. N. Y. Badannavar},
      title = {Synthesis, Characterization, and Biological Evaluation of Compartmental Thiosemicarbazone Metal Complexes},
      journal = {Iconic Research And Engineering Journals},
      year = {2022},
      volume = {6},
      number = {1},
      pages = {726-736},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1703636.pdf},
      abstract = {The research article explores the conceptual design and theoretical implications of thiosemicarbazone ligands as compartmental frameworks capable of coordinating with multiple metal centers simultaneously, focusing on their synthesis through condensation reactions between thiosemicarbazides and aldehydes or ketones to yield ligands with bifunctional or polyfunctional binding sites, their structural characterization using advanced techniques such as X-ray crystallography to reveal coordination geometries, bond lengths, and angles indicative of stable chelation, and their evaluation through computational studies including density functional theory (DFT) to predict electronic distributions and reactivity, emphasizing the role of electronic and steric factors introduced by substituents on the ligand backbone in modulating the coordination environment, while further investigating the catalytic potential of these metal complexes in oxidation and coupling reactions such as the Mizoroki?Heck reaction and their biological activities, with a specific focus on their antimicrobial, anticancer, and antioxidant properties arising from mechanisms like metal-mediated DNA cleavage, generation of reactive oxygen species (ROS), and disruption of enzymatic pathways, supported by theoretical frameworks explaining their activity profiles, along with the limitations posed by solubility, toxicity, and stability issues, which are addressed through theoretical proposals for structural optimizations and the incorporation of advanced delivery systems to enhance their therapeutic and functional applicability, ultimately contributing to a deeper understanding of the coordination chemistry of thiosemicarbazones and their compartmental metal complexes and paving the way for innovative applications in catalysis, material science, and medicinal chemistry.},
      keywords = {Thiosemicarbazone ligands, Compartmental metal complexes, Coordination chemistry, Advanced structural characterization, Catalytic applications, biological activities},
      month = {July},
  }